Sen. Chuck Grassley expressed concern on Monday that the proposed 21st Century CURES Act from the House of Representatives weakens drug and device company reporting requirements under the Physician Payments Sunshine Act. Grassley co-authored the bipartisan sunshine provisions, enacted in 2010. Today, the House of Representatives CURES Act sponsors released a revised bill that removes the provision to weaken the reporting requirements for Continuing Medical Education, medical journal reprints and textbooks. Grassley made the following comment.
“This is good news for transparency and the public. The Sunshine Act works as is. Billions of dollars in drug and device company payments to doctors have been disclosed for public benefit. With drug prices through the roof, the way drug and device makers spend money is of more public interest than ever. Given this change, I no longer plan to object to the CURES Act.”